Grace E. Colón

Grace E. Colón

Director/Board Member bei VOYAGER THERAPEUTICS, INC.

Vermögen: 251 068 $ am 31.03.2024

57 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Grace E.
Colón
is the founder of Pyranose Biotherapeutics, which was founded in 2012.
She is currently the Executive Chairman at ProterixBio, Inc. since 2015, Chairman at Bloom Science, Inc. since 2023, and an Independent Director at CareDx, Inc. since 2019.
Dr. Colón also holds positions as a Director at Biotechnology Innovation Organization, Voyager Therapeutics, Inc., MIT Corp.
(United States), Women Corporate Directors, Latino Corporate Directors Association, and Massachusetts Institute of Technology.
In her former positions, she served as the President, Chief Executive Officer & Director at InCarda Therapeutics, Inc. from 2013 to 2022, Director at Paradigm Diagnostics, Inc. from 2017 to 2019, Director at InterLink AI, Inc. from 2015 to 2019, Director at Cocoon Biotech, Inc. from 2016 to 2020, Vice President-Corporate Planning at Affymetrix, Inc. from 2000 to 2005, President-Industrial Products Division & SVP at Precigen, Inc. from 2010 to 2012, Head-Clinical Operations at Gilead Sciences from 2010 to 2012, Partner at New Science Ventures LLC from 2014 to 2016, Chief Operating Officer at International Genomics Consortium from 2001 to 2002, and Engagement Manager at McKinsey & Co., Inc. from 1996 to 2000.
Dr. Colón obtained an undergraduate degree from the University of Pennsylvania and a doctorate degree from the University of Massachusetts.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
16.06.2023 23 708 ( 0,05% ) 251 068 $ 31.03.2024
06.06.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Grace E. Colón

UnternehmenPositionBeginn
CAREDX, INC Director/Board Member 01.07.2019
VOYAGER THERAPEUTICS, INC. Director/Board Member 01.01.2023
Massachusetts Institute of Technology Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Chairman 17.05.2023
Director/Board Member -
Director/Board Member -
Chairman 01.11.2016
Alle aktiven Positionen von Grace E. Colón

Ehemalige bekannte Positionen von Grace E. Colón

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Grace E. Colón im Detail an

Ausbildung von Grace E. Colón

University of Pennsylvania Undergraduate Degree
University of Massachusetts Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Grace E. Colón im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

22

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
CAREDX, INC

Health Technology

PRECIGEN, INC.

Health Technology

VOYAGER THERAPEUTICS, INC.

Health Technology

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Gilead Sciences /Oncology Operations/

Health Technology

Finance

International Genomics Consortium

Commercial Services

Health Technology

Commercial Services

Consumer Services

Technology Services

Pyranose Biotherapeutics

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Grace E. Colón